Cell line · CVCL_7668
Papers11
1 to 11 of 11
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Inhibition of the LINE1-derived MET transcript induces apoptosis and oncoprotein knockdown in cancer cells. | Mol Ther Nucleic Acids | 2025 | Its Methods give the RRID and name the line | PubMed | |
| E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network. | Cancer Res Commun | 2024 | Its Methods give the RRID and name the line | PubMed | |
| An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies. | Cell Mol Life Sci | 2022 | Its Methods give the RRID and name the line | PubMed | |
Circular RNA Hsa_circRNA_101996 promotes the development of Gastric Cancer via Upregulating Matrix Metalloproteinases-2/Matrix Metalloproteinases-9 through MicroRNA-143/Ten-eleven translocation-2 Pathway. | J Cancer | 2021 | Its Methods give the RRID and name the line | PubMed | |
| TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression. | Genome Med | 2015 | Cellosaurus cites it | PubMed | |
| A comprehensive transcriptional portrait of human cancer cell lines. | Nat Biotechnol | 2015 | Cellosaurus cites it | PubMed | |
| Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer. | Nat Commun | 2014 | Cellosaurus cites it | PubMed | |
| A novel SND1-BRAF fusion confers resistance to c-Met inhibitor PF-04217903 in GTL16 cells through [corrected] MAPK activation. | PLoS One | 2012 | Cellosaurus cites it | PubMed | |
| Karyotypic analysis of gastric carcinoma cell lines carrying an amplified c-met oncogene. | Cancer Genet Cytogenet | 1992 | Cellosaurus cites it | PubMed | |
| c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. | Oncogene | 1991 | Cellosaurus cites it | PubMed | |
| Tyrosine kinase receptor indistinguishable from the c-met protein. | Nature | 1989 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_7668/papers